Monday, October 6, 2014

Active surveillance for prostate cancer: What is it and is it right for me?


PART ONE 

All cancers are not created equal

Prostate cancer is the most commonly diagnosed non-skin malignancy and the second most common cause of cancer death in American men. It is generally accepted that the introduction of PSA screening in the early 1990s led to increased detection of prostate cancer (Figure). While improved detection has been associated with a subsequent decline in prostate cancer death rates (-4.1% annually from 1994 to 2001), the majority of men diagnosed with prostate cancer will ultimately not die of the disease. In fact, there is increasing evidence that many men are diagnosed with low-risk prostate cancers that would not have impacted their quantity or quality-of-life if never detected. Such "overdiagnosis" is problematic because prostate cancer treatments are associated with side effects including erectile dysfunction and urinary issues – which can have a significant impact on quality of life.



The changing landscape of prostate cancer

In light of this, the landscape of diagnosing and treating prostate cancer has shifted dramatically over the past two decades. While physicians previously sought to diagnose all men harboring prostate cancer so that potentially life-sparing treatment could be offered, we now know that most of these men are diagnosed with indolent (or benign-behaving) cancers which will not require treatment at all. Thus, the burden now lies in identifying and treating men with life-threatening cancers -- while sparing men with indolent disease the side effects associated with unnecessary treatment. Given the number of men and families affected by prostate cancer every year, this has appropriately become a major focus of our efforts against the disease.

 

Separating the good from the bad

As described above, prostate cancer presents physicians with quite the dilemma. While prostate cancer is the 2nd leading cause of cancer death in this country (just behind lung cancer), the fact remains that the majority of prostate cancers diagnosed will never become harmful to a man during his lifetime. How, then, can we distinguish the dangerous cancers from the others? As it turns out, years of research have taught us that there are clinical (i.e. patient-related) and pathological (i.e. tumor-related) factors that help a great deal in doing so. While this process of dividing cancers based on the threat they pose, termed "risk-stratification," is the subject of many conferences and careers, a few of the most pertinent questions used to stratify prostate cancers are listed below:
  • Was an abnormality of the prostate (e.g. nodule, firmness) detected during digital rectal exam?
  • What was the level of prostate-specific antigen (PSA) detected on a routine blood test?
  • How much cancer was identified on prostate biopsy?
  • How disorganized did the cancer cells appear on the pathologist's microscopic examination?
Using detailed answers to these questions, the National Comprehensive Cancer Network (NCCN) has developed prostate cancer risk levels that patients and physicians can use to help guide management decisions. Men with localized prostate cancer (i.e. no evidence of cancer outside the prostate) will fall into one of the following risk categories: very low risk (VLR), low risk (LR), intermediate risk, or high risk. This is all to say that men in the more favorable risk groups are the same men discussed above – many of whom may not benefit from undergoing treatment. Identifying the men who will benefit from treatment, however, requires watching these men closely for any evidence that their cancer is more dangerous than we originally thought. This practice is known as "active surveillance" (AS) and is described in greater detail below.

 

What is active surveillance?

Active surveillance is a management strategy that consists of carefully monitoring men with favorable-risk prostate cancer using repeat PSA values, biopsies, and other tests such as MRI. If higher-risk features appear during follow up, curative treatment (e.g. surgery or radiation) is recommended on the presumption that treatment can still occur within the window of opportunity for cure. Given this, the basic tenet of AS rests upon our knowledge that most prostate cancers are slow-growing and a delay in treatment does not compromise the chance to cure.

 

Which men are candidates for active surveillance?

While the exact criteria used to select candidates for AS vary among institutions, the majority of programs offer surveillance to men with VLR and LR cancer, and in some cases it may be appropriate to consider in men with intermediate risk disease as well. Another important consideration is a man's overall life expectancy. Men who are otherwise healthy and expected to live for another 10 years or longer are more likely to be harmed even by lower-risk cancers; these men are usually recommended to undergo treatment. At Johns Hopkins, we initially offered AS to men with VLR disease, although certain men with LR disease are good candidates as well. Men with intermediate risk cancers are in rare instances considered as well (see table). Regardless, all men considering AS should have an in-depth discussion with their urologist regarding its risks and benefits. Specific entry criteria and considerations at the time of entry are listed in the table below, followed by a tool which can provide an estimate of life expectancy (Cho et al.).


RISK
CRITERIA
RECOMMENDATION
Very low
PSA
<10
Gleason Score <7 and stage T1c and PSA density <0.15 and unilateral disease with <3 cores containing cancer regardless of percent core involvement
·         Any age if patient prefers surveillance
·         Preferred if life expectancy is less than 20 years
PSA
10-20
Gleason Score <7 and stage T1c and PSA density <0.10 and unilateral disease with <3 cores containing cancer regardless of percent core involvement
·         Any age if patient prefers surveillance
·         Preferred if life expectancy is less than 20 years
Low
Stage T1c or T2a and Gleason score <7 and PSA <10
·         Age >65 years
·         Preferred if life expectancy is less than 10 years
Intermediate
Stage T2b or T2c or Gleason score 3+4 or PSA 10-20 (not very low risk)
·         Life expectancy is less than 10 years
High
Stage T3 or Gleason score >3+4 or PSA >20
·         Not recommended



Gleason refers to Gleason scores. PSA density is PSA divided by prostate volume determined by ultrasound or MRI.



As we will discuss further, participation in active surveillance requires a patient committed to repeat tests and examinations. In our next entry, we will discuss the basic follow-up protocol for AS, why some men ultimately undergo treatment, and what we know about the safety of our surveillance program and others.

Stay tuned to read Part Two. 
For a more detailed explanation of the pathology used to grade prostate cancer, and additional information regarding active surveillance, visit the Johns Hopkins Active Surveillance Program website: http://www.urology.jhu.edu/prostate/advice1.php?lk=RL4


The Blog was written by Jeffrey Tosoian, MD (@UroDocJT). Dr. Tosoian is a PGY3 (Post-Graduate Year 3) urology resident at the Brady Urological Institute at Johns Hopkins.

7 comments:

  1. Men frequently have prostatitis for quite a long time without experiencing symptoms or without realizing the signs are associated with prostatitis. Prostatitis is inflammation of the prostate gland. Affected person should prostatitis disease treatment.

    ReplyDelete
    Replies
    1. Having cancer is a Terrible Experience, my names are MARY JOHNSON I’m a citizen of United STATE,i was suffering of breast cancer and my family have taking me to all kind of hospital in US still yet no good result. I decided to go to the internet and search for cancer cure, so that was how I find a lady called ERIC PAULA she was testifies to the world about the goodness of a herbal man who has the root and herbs to cure all kind of disease and the herbal man email was there. So I decided to contact the herbal man for help to cure me from breast cancer. I contacted him and told him my problem he told me that I should not worry that my cancer will be cured, he told me that there is a medicine that he is going to give me that I will cook it and start drinking it for 2 weeks, so I ask how can I receive the cure that I am in US, he told me that I will pay for the delivery service. The courier service can transport it to me so he told me the amount I will pay, so my dad paid for the delivery fee. two days later I receive the cure from the courier service so i started using it as the herbal man instructed me to do before the week complete my cancer was healed and it was like a dream to me not knowing that it was physical I and my family were very happy about the miracle of Doctor so my dad wanted to pay him 2 million us dollars the herbal man did not accept the offer from my dad, but I don't know why he didn't accept the offer, he only say that I should tell the world about him and his miracle he perform so am now here to tell the world about him if you or your relative is having any kind of disease that you can't get from the hospital please contact drosohaberhome@gmail.com or call/whats-app +2348162084839 ....

      here is the dr website.
      https://sites.google.com/view/drosohaberhome/
      His blog page https://drosohaberhome.blogspot.com

      you can also email me for more info about DR oso via maryjohnson9700@gmail.com ALL THANK TO DR OSO ..

      Delete
  2. I’m excited to uncover this page. I need to to thank you for ones time for this particularly fantastic read!! I definitely really liked every part of it and i also have you saved to fav to look at new information in your site.Asbestos Cancer Organization

    ReplyDelete
  3. The primary level is a one-off screening process, that's generally called bowel scope screening. The bowel scope screening manner is the primary interplay in this system in most cases happens at both age 50 and fifty five. The second level is the at-home trying out package dispatched to sufferers. Sufferers typically get the package every 24 months See More.

    ReplyDelete
  4. One or more players are usually required to make forced bets, usually either an ante or a blind bet (sometimes both). agen bandarq

    ReplyDelete
  5. Having cancer is a Terrible Experience, my names are MARY JOHNSON I’m a citizen of United STATE,i was suffering of breast cancer and my family have taking me to all kind of hospital in US still yet no good result. I decided to go to the internet and search for cancer cure, so that was how I find a lady called ERIC PAULA she was testifies to the world about the goodness of a herbal man who has the root and herbs to cure all kind of disease and the herbal man email was there. So I decided to contact the herbal man for help to cure me from breast cancer. I contacted him and told him my problem he told me that I should not worry that my cancer will be cured, he told me that there is a medicine that he is going to give me that I will cook it and start drinking it for 2 weeks, so I ask how can I receive the cure that I am in US, he told me that I will pay for the delivery service. The courier service can transport it to me so he told me the amount I will pay, so my dad paid for the delivery fee. two days later I receive the cure from the courier service so i started using it as the herbal man instructed me to do before the week complete my cancer was healed and it was like a dream to me not knowing that it was physical I and my family were very happy about the miracle of Doctor so my dad wanted to pay him 2 million us dollars the herbal man did not accept the offer from my dad, but I don't know why he didn't accept the offer, he only say that I should tell the world about him and his miracle he perform so am now here to tell the world about him if you or your relative is having any kind of disease that you can't get from the hospital please contact drosohaberhome@gmail.com or call/whats-app +2348162084839 ....

    here is the dr website.
    https://sites.google.com/view/drosohaberhome/
    His blog page https://drosohaberhome.blogspot.com

    you can also email me for more info about DR oso via maryjohnson9700@gmail.com ALL THANK TO DR OSO .

    ReplyDelete